Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Making sense of human biomonitoring data: Findings and recommendations of a workshop

Abstract

The ability to measure chemicals in humans (often termed biomonitoring) is far outpacing the ability to interpret reliably these data for public health purposes, creating a major knowledge gap. Until this gap is filled, the great promise of routinely using biomonitoring data to support decisions to protect public health cannot be realized. Research is needed to link biomonitoring data quantitatively to the potential for adverse health risks, either through association with health outcomes or using information on the concentration and duration of exposure, which can then be linked to health guidelines. Developing such linkages in the risk assessment paradigm is one of the primary goals of the International Council of Chemical Associations' (ICCA) Long-Range Research Initiative (LRI) program in the area of biomonitoring. Therefore, ICCA sponsored a workshop to facilitate development of a coordinated agenda for research to enable an improved interpretation of human biomonitoring data. Discussions addressed three main topics: (1) exploration of the link between exposure, dose, and human biomonitoring data, (2) the use of computational tools to interpret biomonitoring data, and (3) the relevance of human biomonitoring data to the design of toxicological studies. Several overarching themes emerged from the workshop: (a) Interpretation and use of biomonitoring data should involve collaboration across all sectors (i.e., industry, government, and academia) and countries. (b) Biomonitoring is not a stand-alone tool, and it should be linked to exposure and toxicological dose information. (c) Effective communication is critical, because when uncertainty about the actual risks is high, the perceived risks grow in the absence of communication. (d) The scope of future biomonitoring activities encompasses a variety of research approaches — from advancing the science to fill data gaps to advancing the accessibility of the current knowledge to enable better information sharing.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Abbreviations

ACC:

American Chemistry Council

ADME:

absorption, distribution, metabolism, and elimination

AUC:

area-under-the-curve

CDC:

Centers for Disease Control and Prevention

Cefic:

the European chemical industry council

ECETOC:

European Centre for Ecotoxicology and Toxicology of Chemicals

EPA:

US Environmental Protection Agency

EU:

European Union

ICCA:

International Council of Chemical Associations

ILSI/HESI:

International Life Science Institute Health and Sciences Institute

JCIA:

Japan Chemical Industries Association

LRI:

Long-Range Research Initiative

MOE:

margin of exposure

NGO:

non-governmental organization

NOAEL:

no observable adverse effects limit

NRC:

National Research Council

OECD:

Organisation for Economic Co-operation and Development

PBPK:

physiologically based pharmacokinetic

QSAR:

quantitative structure–activity relationships

QSPR:

quantitative structure–property relationship

RfD:

reference dose

References

  • European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC). Guidance for the Interpretation of Biomonitoring Data, 2005. Document number 44. November 30, 2005.

  • National Research Council (NRC). Human Biomonitoring for Environmental Chemicals. NRC Committee on Human Biomonitoring for Environmental Toxicants, 2006. July 2006.

Download references

Acknowledgements

We thank the entire Scientific Organizing Committee, including Rick Becker, American Chemistry Council; Ben Blount, Centers for Disease Control and Prevention; Laurent Bontoux, European Union Joint Research Centre; Peter Boogaard, Shell Health Services – Shell International BV; Akira Fukushima Lion Corporation, Japan; Annette Guiseppi-Elie, Dupont; Doug Haines, Health Canada; Masatoshi Kumamoto, Japan Chemical Industry Association; Marsha Morgan, US EPA; Moiz Mumtaz, Centers for Disease Control and Prevention; Larry Needham, Centers for Disease Control and Prevention; and Miles Okino, US EPA. This meeting report summarizes recommendations that were generated by the workshop participants. The views expressed do not necessarily represent positions of the participating organizations, nor do they represent an endorsement of any particular product or vendor.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tina Bahadori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bahadori, T., Phillips, R., Money, C. et al. Making sense of human biomonitoring data: Findings and recommendations of a workshop. J Expo Sci Environ Epidemiol 17, 308–313 (2007). https://doi.org/10.1038/sj.jes.7500581

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jes.7500581

Keywords

This article is cited by

Search

Quick links